Author: Laila Zulfa

The United States Food and Drug Administration (FDA) has officially launched a centralized digital platform designed to consolidate its various safety surveillance databases into a single, unified dashboard. This strategic overhaul, aimed at modernizing the way the agency monitors adverse events related to drugs, vaccines, biologics, and other consumer products, represents a significant shift in…

Insulet Corporation, a prominent leader in tubeless insulin pump technology, has disclosed in a recent federal financial filing that it anticipates incurring significant expenses related to a corrective action involving its flagship product, the Omnipod 5 Automated Insulin Delivery (AID) system. According to the filing submitted to the Securities and Exchange Commission (SEC), the Massachusetts-based…

Intuitive Surgical, the global leader in robotic-assisted surgery, has confirmed a significant cybersecurity breach involving the unauthorized access of sensitive corporate, employee, and customer data. The Sunnyvale, California-based company revealed that the incident stemmed from a sophisticated phishing campaign that targeted a specific employee, allowing a third party to infiltrate the firm’s internal business administrative…

Stryker, a global leader in medical technology, confirmed this week that a sophisticated cyberattack has significantly impacted its internal systems, leading to widespread disruptions in manufacturing, order processing, and shipping operations. The Portage, Michigan-based company, which plays a critical role in the global healthcare supply chain through the production of surgical equipment, orthopedic implants, and…

Stryker Corporation, a leading global medical technology firm, is currently navigating the aftermath of a sophisticated cyberattack that has triggered widespread disruption across its international network and Microsoft-based digital environment. The Portage, Michigan-based company, which plays a critical role in the global healthcare supply chain, confirmed the breach after identifying unauthorized activity within its systems…

Insulet Corporation has officially outlined its roadmap for the commercialization of its next-generation insulin delivery technology, aiming for a 2028 market entry for its fully closed-loop system. During a recent earnings call and subsequent data releases, the company confirmed plans to initiate a pivotal clinical trial this year, which will serve as the foundation for…

The Trump administration has officially initiated a broad request for public input regarding potential regulatory overhauls aimed at dismantling sophisticated fraud schemes targeting federal healthcare programs, specifically within the rapidly expanding sector of genetic and molecular diagnostic testing. This move, spearheaded by the Centers for Medicare and Medicaid Services (CMS), signals an aggressive pivot toward…

The United States Food and Drug Administration (FDA) has issued a formal warning letter to Exactech, a prominent manufacturer of orthopedic implants, following a detailed inspection of its production facility in Sarasota, Florida. The regulatory action highlights significant systemic failures in quality control, manufacturing specifications, and environmental monitoring, marking another chapter in the company’s ongoing…

The Danish medical device giant Coloplast has officially concluded its ten-month search for a permanent leader by appointing Gavin Wood, a veteran of the global healthcare industry, as its new Chief Executive Officer. Wood, who most recently served as the Company Group Chairman for Johnson & Johnson MedTech in the Europe, Middle East, and Africa…

Medtronic, a global leader in medical technology, has officially announced the promotion of Sean Haag to the position of President of its Ear, Nose, and Throat (ENT) business. The appointment, confirmed by the company on Tuesday, marks the culmination of a successful transition period during which Haag served as the interim leader of the division.…